Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Հիմնական հեղինակներ: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
National Institute for Health Research
2016
|
Նմանատիպ նյութեր
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
: Thomas RE Barnes, և այլն
Հրապարակվել է: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
: Barnes, T, և այլն
Հրապարակվել է: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
: Stephanie C. Chen, և այլն
Հրապարակվել է: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
: Thomas RE Barnes, և այլն
Հրապարակվել է: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
: Crawford, A, և այլն
Հրապարակվել է: (2014)